Euphylong

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1986-1998
024619861998

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
In a multiple-dose crossover study in 18 healthy male volunteers the steady-state pharmacokinetics of Euphylong, which has been… (More)
Is this relevant?
1991
1991
25 patients suffering from chronic obstructive lung disease with a delta FEV1 greater than 15% were included in an open… (More)
Is this relevant?
1991
1991
The long-term stability of morning serum theophylline concentrations (STC) and peak expiratory flow (PEF) was investigated for at… (More)
Is this relevant?
1991
1991
In this study we examined the efficacy and pharmacokinetics of a new chrono-optimized theophylline sustained release preparation… (More)
Is this relevant?
1991
1991
24 patients with COPD and delta FEV1 greater than 15% were included in a double-blind crossover study. 7 dropouts due to… (More)
Is this relevant?
1990
1990
Euphylong is a theophylline preparation with new galenic slow-release design (micropellets in a capsule), developed for daily… (More)
Is this relevant?
1988
1988
Although bioequivalence between products has gained considerable importance over the last few years, the concept has not yet been… (More)
Is this relevant?
1988
1988
Euphylong is a new anhydrous theophylline sustained-release pellet formulation developed for once-daily administration in the… (More)
Is this relevant?
1987
1987
Three separate single-dose, randomized, cross-over studies in normal, healthy volunteers were performed to investigate the… (More)
Is this relevant?
1986
1986
In a randomized, multiple-dose, cross-over study, serum theophylline concentrations (STC) were compared in 12 healthy volunteers… (More)
Is this relevant?